ResearcherWakayama Medical UniversityActive in the last 2 years
Hideki Motobayashi
Matched on OpenAlex author ID A5020393701. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 56
2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers
Papers 8
- Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study. Co-author DOI 10.1007/s00535-026-02432-2↗
- Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD trial): A Multicenter Randomized Controlled… Co-author DOI 10.1097/sla.0000000000006900↗
- Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes over 5-year follow-up. Co-author DOI 10.1016/j.suronc.2025.102248↗
- Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1002/jhbp.1436↗
- Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00432-023-05594-1↗
- Identification of a urinary CD276 fragment for detecting resectable pancreatic cancer using a C-terminal proteomics strategy. Co-author DOI 10.1038/s41598-024-65093-2↗
- Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2023.06.012↗
- Circulating Tumor DNA as a Potential Prognostic Marker in Patients with Borderline-Resectable Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy Followed by… Co-author DOI 10.1245/s10434-021-10985-0↗
Closest collaborators
The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuji Kitahata · 7 shared papers, 2022–2026 · strength 1.36
- Paper Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes ove… DOI 10.1016/j.suronc.2025.102248↗
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
- Manabu Kawai · 5 shared papers, 2022–2025 · strength 0.93
- Paper Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes ove… DOI 10.1016/j.suronc.2025.102248↗
- Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Tomohiro Yoshimura · 4 shared papers, 2023–2025 · strength 0.78
- Paper Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes ove… DOI 10.1016/j.suronc.2025.102248↗
- Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Atsushi Miyamoto · 4 shared papers, 2022–2025 · strength 0.72
- Paper Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes ove… DOI 10.1016/j.suronc.2025.102248↗
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Hiroki Yamaue · 4 shared papers, 2022–2026 · strength 0.71
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Atsushi Shimizu · 3 shared papers, 2023–2024 · strength 0.54
- Paper Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic… DOI 10.1002/jhbp.1436↗
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Seiko Hirono · 3 shared papers, 2022–2026 · strength 0.54
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Paper Circulating Tumor DNA as a Potential Prognostic Marker in Patients with Borderline-Resectable Pancreatic Cancer Undergo… DOI 10.1245/s10434-021-10985-0↗
- Ken‐ichi Okada · 3 shared papers, 2022–2024 · strength 0.49
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Paper Circulating Tumor DNA as a Potential Prognostic Marker in Patients with Borderline-Resectable Pancreatic Cancer Undergo… DOI 10.1245/s10434-021-10985-0↗
- Motoki Miyazawa · 3 shared papers, 2022–2024 · strength 0.49
- Paper Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic … DOI 10.1007/s00432-023-05594-1↗
- Paper Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ducta… DOI 10.1016/j.ejso.2023.06.012↗
- Paper Circulating Tumor DNA as a Potential Prognostic Marker in Patients with Borderline-Resectable Pancreatic Cancer Undergo… DOI 10.1245/s10434-021-10985-0↗
- Sohei Satoi · 2 shared papers, 2026 · strength 0.41
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nati… DOI 10.1007/s00535-026-02432-2↗
- Keiko Kamei · 2 shared papers, 2026 · strength 0.41
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nati… DOI 10.1007/s00535-026-02432-2↗
- Masayuki Sho · 2 shared papers, 2026 · strength 0.41
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nati… DOI 10.1007/s00535-026-02432-2↗
- Kenichiro Uemura · 2 shared papers, 2026 · strength 0.41
- Paper Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD tri… DOI 10.1097/sla.0000000000006900↗
- Paper Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nati… DOI 10.1007/s00535-026-02432-2↗
- Akimasa Nakao · 1 shared paper, 2026 · strength 0.23
- Masaaki Hidaka · 1 shared paper, 2026 · strength 0.23
- Kenjiro Kimura · 1 shared paper, 2026 · strength 0.23
- Hiromitsu Hayashi · 1 shared paper, 2026 · strength 0.23
- Masafumi Nakamura · 1 shared paper, 2026 · strength 0.23
- Ryo Morimura · 1 shared paper, 2026 · strength 0.23
- Yuichi Nagakawa · 1 shared paper, 2026 · strength 0.23
- Yuko Mataki · 1 shared paper, 2026 · strength 0.23
- Ken‐ichi Okada · 1 shared paper, 2024 · strength 0.21
- Shuichi Mitsunaga · 1 shared paper, 2024 · strength 0.20
- Masafumi Ikeda · 1 shared paper, 2024 · strength 0.20
- Kohei Nakata · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.